Joen R. Sheu

1.0k total citations
24 papers, 874 citations indexed

About

Joen R. Sheu is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Hematology. According to data from OpenAlex, Joen R. Sheu has authored 24 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmacology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Hematology. Recurrent topics in Joen R. Sheu's work include Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Antioxidant Activity and Oxidative Stress (4 papers) and Platelet Disorders and Treatments (3 papers). Joen R. Sheu is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Antioxidant Activity and Oxidative Stress (4 papers) and Platelet Disorders and Treatments (3 papers). Joen R. Sheu collaborates with scholars based in Taiwan, India and United States. Joen R. Sheu's co-authors include George Hsiao, Duen S. Chou, Kuan‐Hung Lin, Ming‐Yi Shen, Yi Chang, Wan‐Jung Lu, Chien‐Huang Lin, Ming‐Jen Hsu, Thanasekaran Jayakumar and Tur‐Fu Huang and has published in prestigious journals such as Journal of Biological Chemistry, Arteriosclerosis Thrombosis and Vascular Biology and Anesthesiology.

In The Last Decade

Joen R. Sheu

24 papers receiving 854 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Joen R. Sheu Taiwan 16 279 132 125 117 113 24 874
Wan‐Jung Lu Taiwan 22 479 1.7× 155 1.2× 219 1.8× 154 1.3× 135 1.2× 54 1.2k
Halina Małgorzata Żbikowska Poland 19 299 1.1× 99 0.8× 72 0.6× 53 0.5× 70 0.6× 42 1.1k
Amit Joharapurkar India 23 489 1.8× 109 0.8× 73 0.6× 149 1.3× 57 0.5× 71 1.3k
Zhangyin Ming China 19 556 2.0× 107 0.8× 71 0.6× 108 0.9× 153 1.4× 39 1.3k
Andreina Poggi Italy 17 446 1.6× 141 1.1× 43 0.3× 150 1.3× 91 0.8× 32 1.2k
Jingyi Tang China 17 363 1.3× 65 0.5× 103 0.8× 60 0.5× 51 0.5× 57 886
Tsutomu Yamashita Japan 20 191 0.7× 140 1.1× 58 0.5× 96 0.8× 268 2.4× 60 1.1k
Hui-jun Yin China 18 397 1.4× 102 0.8× 272 2.2× 89 0.8× 121 1.1× 80 907
Yueyi Deng China 15 315 1.1× 86 0.7× 181 1.4× 136 1.2× 57 0.5× 39 1.1k
Duen S. Chou Taiwan 9 156 0.6× 60 0.5× 74 0.6× 67 0.6× 73 0.6× 12 522

Countries citing papers authored by Joen R. Sheu

Since Specialization
Citations

This map shows the geographic impact of Joen R. Sheu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joen R. Sheu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joen R. Sheu more than expected).

Fields of papers citing papers by Joen R. Sheu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joen R. Sheu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joen R. Sheu. The network helps show where Joen R. Sheu may publish in the future.

Co-authorship network of co-authors of Joen R. Sheu

This figure shows the co-authorship network connecting the top 25 collaborators of Joen R. Sheu. A scholar is included among the top collaborators of Joen R. Sheu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joen R. Sheu. Joen R. Sheu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Wan‐Jung, Chi‐Li Chung, Li Huang, et al.. (2018). An Antithrombotic Strategy by Targeting Phospholipase D in Human Platelets. Journal of Clinical Medicine. 7(11). 440–440. 5 indexed citations
2.
Chang, Yi, et al.. (2013). Brazilin isolated from Caesalpinia sappan L. acts as a novel collagen receptor agonist in human platelets. Journal of Biomedical Science. 20(1). 4–4. 19 indexed citations
3.
Lin, Kuan‐Hung, Wan‐Jung Lu, Chi‐Li Chung, et al.. (2013). Hinokitiol inhibits platelet activation ex vivo and thrombus formation in vivo. Biochemical Pharmacology. 85(10). 1478–1485. 39 indexed citations
4.
Lu, Wan‐Jung, Kuan‐Hung Lin, Ming‐Jen Hsu, et al.. (2012). Suppression of NF-κB signaling by andrographolide with a novel mechanism in human platelets: Regulatory roles of the p38 MAPK-hydroxyl radical-ERK2 cascade. Biochemical Pharmacology. 84(7). 914–924. 63 indexed citations
5.
Hsu, Ming‐Jen, et al.. (2010). Andrographolide Enhances Nuclear Factor-κB Subunit p65 Ser536 Dephosphorylation through Activation of Protein Phosphatase 2A in Vascular Smooth Muscle Cells. Journal of Biological Chemistry. 286(8). 5942–5955. 73 indexed citations
6.
Chang, Yi, et al.. (2010). A novel role for tamoxifen in the inhibition of human platelets. Translational research. 157(2). 81–91. 17 indexed citations
7.
Chang, Chao, Wan‐Jung Lu, Thanasekaran Jayakumar, et al.. (2009). Potent antiplatelet activity of sesamol in an in vitro and in vivo model: pivotal roles of cyclic AMP and p38 mitogen-activated protein kinase. The Journal of Nutritional Biochemistry. 21(12). 1214–1221. 32 indexed citations
8.
Lin, Kuan‐Hung, et al.. (2009). Comparison of the relative activities of inducing platelet apoptosis stimulated by various platelet-activating agents. Platelets. 20(8). 575–581. 22 indexed citations
9.
Shen, Ming‐Yi, George Hsiao, Duen S. Chou, et al.. (2008). Amyloid beta peptide-activated signal pathways in human platelets. European Journal of Pharmacology. 588(2-3). 259–266. 42 indexed citations
10.
Shen, Ming‐Yi, et al.. (2007). Inhibitory mechanisms of resveratrol in platelet activation: pivotal roles of p38 MAPK and NO/cyclic GMP. British Journal of Haematology. 139(3). 475–485. 123 indexed citations
11.
Hsiao, George, et al.. (2005). A potent antioxidant, lycopene, affords neuroprotection against microglia activation and focal cerebral ischemia in rats.. PubMed. 18(3). 351–6. 89 indexed citations
12.
Sheu, Joen R., et al.. (2004). Expression of matrix metalloproteinase‐9 in human platelets: regulation of platelet activation in in vitro and in vivo studies. British Journal of Pharmacology. 143(1). 193–201. 73 indexed citations
13.
Shen, Ming‐Yi, et al.. (2003). Antithrombotic Effects of Magnesium Sulfate in In Vivo Experiments. International Journal of Hematology. 77(4). 414–419. 10 indexed citations
14.
Hou, Charles Jia‐Yin, et al.. (2002). Comparison of clinical features and outcome in massive and non-massive pulmonary embolism. 18(4). 173–180. 2 indexed citations
15.
Sheu, Joen R., et al.. (2001). Antithrombotic Effects of Tetramethylpyrazine in In Vivo Experiments. International Journal of Hematology. 73(3). 393–398. 13 indexed citations
16.
Lin, Chien‐Huang, et al.. (2000). Involvement of protein kinase C-gamma in IL-1beta-induced cyclooxygenase-2 expression in human pulmonary epithelial cells.. PubMed. 57(1). 36–43. 55 indexed citations
17.
Sheu, Joen R., et al.. (1999). The antiplatelet activity of PMC, a potent α‐tocopherol analogue, is mediated through inhibition of cyclo‐oxygenase. British Journal of Pharmacology. 127(5). 1206–1212. 23 indexed citations
18.
19.
Sheu, Joen R., et al.. (1993). Triflavin, an Arg‐Gly‐Asp‐containing Peptide, Inhibits Tumor Cell‐induced Platelet Aggregation. Japanese Journal of Cancer Research. 84(10). 1062–1071. 9 indexed citations
20.
Sheu, Joen R., et al.. (1992). Triflavin, an Arg‐Gly‐Asp‐containing Antiplatelet Peptide Inhibits Cell‐substratum Adhesion and Melanoma Cell‐induced Lung Colonization. Japanese Journal of Cancer Research. 83(8). 885–893. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wan‐Jung Lu Breakdown of academic impact, for papers by Halina Małgorzata Żbikowska Breakdown of academic impact, for papers by Amit Joharapurkar Breakdown of academic impact, for papers by Zhangyin Ming Breakdown of academic impact, for papers by Andreina Poggi Breakdown of academic impact, for papers by Jingyi Tang Breakdown of academic impact, for papers by Tsutomu Yamashita Breakdown of academic impact, for papers by Hui-jun Yin Breakdown of academic impact, for papers by Yueyi Deng Breakdown of academic impact, for papers by Duen S. Chou
Rankless by CCL
2026